Jatoi A - Search Results

1

Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients.

Doles JD, Hogan KA, O'Connor J, Wahner Hendrickson AE, Huston O, Jatoi A. Doles JD, et al. Among authors: jatoi a. J Palliat Med. 2018 Sep;21(9):1334-1338. doi: 10.1089/jpm.2018.0023. Epub 2018 May 24. J Palliat Med. 2018. PMID: 29792535 Free PMC article.

2

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.

Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, Nguyen PL, Kugler J; North Central Cancer Treatment Group. Jatoi A, et al. Support Care Cancer. 2005 Jun;13(6):381-6. doi: 10.1007/s00520-005-0787-6. Epub 2005 Mar 10. Support Care Cancer. 2005. PMID: 15759136

3

Omega-3 fatty acid supplements for cancer-associated weight loss.

Jatoi A. Jatoi A. Nutr Clin Pract. 2005 Aug;20(4):394-9. doi: 10.1177/0115426505020004394. Nutr Clin Pract. 2005. PMID: 16207679 Review.

4

Pharmacological options for advanced cancer patients with loss of appetite and weight.

Behl D, Jatoi A. Behl D, et al. Among authors: jatoi a. Expert Opin Pharmacother. 2007 Jun;8(8):1085-90. doi: 10.1517/14656566.8.8.1085. Expert Opin Pharmacother. 2007. PMID: 17516872 Review.

5

Weight loss in patients with advanced cancer: effects, causes, and potential management.

Jatoi A. Jatoi A. Curr Opin Support Palliat Care. 2008 Mar;2(1):45-8. doi: 10.1097/SPC.0b013e3282f4b734. Curr Opin Support Palliat Care. 2008. PMID: 18685394 Review.

6

Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care.

Huang J, Jatoi A. Huang J, et al. Among authors: jatoi a. J Palliat Med. 2009 Mar;12(3):219-22. doi: 10.1089/jpm.2008.0231. J Palliat Med. 2009. PMID: 19254194 Free PMC article.

7

E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication.

Hartgers M, Jatoi A. Hartgers M, et al. Among authors: jatoi a. J Palliat Med. 2010 Mar;13(3):335-7. doi: 10.1089/jpm.2009.0215. J Palliat Med. 2010. PMID: 20178438 Free PMC article.

8

What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey.

Behl D, Jatoi A. Behl D, et al. Among authors: jatoi a. J Palliat Med. 2010 Jul;13(7):831-5. doi: 10.1089/jpm.2009.0414. J Palliat Med. 2010. PMID: 20636153 Free PMC article.

9

Parenteral nutrition in patients with cancer: recent guidelines and a need for further study.

Burnette B, Jatoi A. Burnette B, et al. Among authors: jatoi a. Curr Opin Support Palliat Care. 2010 Dec;4(4):272-5. doi: 10.1097/SPC.0b013e32833ed6aa. Curr Opin Support Palliat Care. 2010. PMID: 20802337 Review.

10

Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment.

Coleman S, Peethambaram PP, Jatoi A. Coleman S, et al. Among authors: jatoi a. J Cancer Educ. 2011 Sep;26(3):474-7. doi: 10.1007/s13187-010-0166-y. J Cancer Educ. 2011. PMID: 20857352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters